Eye Manifestations Clinical Trial
Official title:
Chosen Parameters of the Immune Response in the Origin of Ocular Changes in Patients With Cystic Fibrosis
Cystic fibrosis(CF) is an inherited disease affecting children, adolescents and young adults with dysfunction of secretory glands.It is caused by mutations in the protein-coding gene which function as the cystic fibrosis transmembrane regulator (CFTR), responsible for the secretion of chloride ions in epithelial cells, adenocytes, sweat gland cells, pancreatic ducts,alimentary and respiratory tracts and eye. Assessment of the relationship between the inflammatory processes and apoptosis in the eye in the course of cystic fibrosis will allow determination of immunological exponents which may facilitate diagnosis.
The aim: To assess the role of chosen parameters of immunological response in the induction of ocular changes in cystic fibrosis patients, particularly chosen chemokine concentrations in the tear fluid and analysis of chosen apoptotic markers expression on conjunctival epithelial cells. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01588041 -
Intraoperative OCT Guidance of Intraocular Surgery
|
||
| Recruiting |
NCT05863689 -
Microvascular Ocular Changes of Systemic Lupus Erythematous
|
||
| Completed |
NCT06235346 -
Ocular Effects of Synthetic Cannabinoids
|
||
| Completed |
NCT04776863 -
Effect of Smokeless Tobacco on Anterior Segment
|
||
| Completed |
NCT04831047 -
The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance
|
Phase 4 | |
| Recruiting |
NCT02912780 -
Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit
|
N/A | |
| Completed |
NCT04021225 -
Comparison of Ectoin® Containing Eye Drops and Ectoin® Containing Eye Spray With the Eye Spray Tears Again®
|
N/A |